AzTrials
AzTrials

Amputation; Traumatic, HandNCT05155735

Functional Outcomes of Single Digit Replantation Versus Revision Amputation

An observational study of Amputation; Traumatic, Hand, run by Centre hospitalier de l'Université de Montréal (CHUM) at 1 site in Canada.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

The purpose of this study is to compare functional outcomes in single digit replantation subjects compared with revision amputation. Functional outcomes will be assessed by DASH (disabilities of the arm, shoulder and hand) score and with Purdue Pegboard Test by the subject's respective hand therapist at their last… Read more about this study

Who is it for?
Ages 18 to 99 years
Conditions the study is for
Amputation; Traumatic, Hand
What is being tested?
Replantation and Primary wound closure
Type of treatment
Surgery or procedure
How many people
30 participants
Where
1 siteCanada
Study dates
17 Jan 2023to 15 Nov 2024
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 99 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Study population: All subjects who have suffered a single digit amputation who are treated at the collaborating hospital centres

Who may be able to join

  • Replantation of single digits treated at collaborating hospital centres
  • Revision amputation of single digits treated at collaborating hospital centres

Who cannot join

  • Thumb amputation
  • Multiple digit amputation
  • Failure to follow-up with hand therapist

Trial locations and contacts

1 site in 1 country.

Canada1 site, 1 recruiting
  • Maisonneuve-Rosemont Hospital

    Montreal East, Quebec, H1T2M4

    Ophelie Doucet, MD, 438-882-9681, ophelie.doucet@umontreal.ca

    Recruiting

Other trials in Canada

About this study

Official title: Functional Outcomes of Single Digit Replantation Versus Revision Amputation, a Prospective Study

The purpose of this study is to compare functional outcomes in single digit replantation subjects compared with revision amputation. Functional outcomes will be assessed by DASH (disabilities of the arm, shoulder and hand) score and with Purdue Pegboard Test by the subject's respective hand therapist at their last visit. Results will contribute to generating a preoperative decision algorithm for single digit amputation injuries.

Read the detailed description

Research design: Prospective observational cohort study

Study population, enrollment, and duration of participation:

Collaborating institutions Revision amputation cohort: CHUM, Santa Cabrini Hospital and Maisonneuve Rosemont Hospital Replantation cohort: CEVARMU/CHUM

Inclusion Criteria: All replantation and revision amputation of single digits who are treated at the collaborating hospital centres Exclusion Criteria: Thumb amputation, Multiple digit amputation, Failure to follow-up with an occupational therapist

Enrollment:

Database encompassing regional plastic surgery interventions will be reviewed to target patients who underwent single digit replantation and revision amputation in the last year, up until the first patient that is not scheduled to come back for evaluation with his hand therapist (as not to introduce a selection bias). Going forward we will run prospectively until we have sufficient data to yield significant results, as the rarity of single digit replantation will be the limiting factor. On call plastic surgery residents at our institution will also be advised to contact the research personnel when they encounter possible candidates at the participating hospitals. The research personnel will in no instance intervene nor influence the decision-making process leading to either revision amputation or replantation of the single digit. Post-operatively, the research personnel will review the patient files to select participants meeting the selection criteria.

Participants will be classified to the following groups according to the intervention performed:

  • Replantation group
  • Revision amputation group
  • Crossover group (initially replanted, then underwent revision amputation) Subgroups
  • Injured digit (index, middle, ring, little)
  • Injury level: Tamai classification
  • Zone 1 (distal to FDP insertion)
  • Zone 2 (distal to interphalangeal joint until FDP insertion)
  • Zone 3 (middle phalanx distal to FDS insertion)
  • Zone 4 (proximal phalanx until middle phalanx FDS insertion) o Zone 5 (metacarpophalangeal joint and proximal)
  • Mechanism of injury o Guillotine
  • Minor crush
  • Major crush o Avulsion

The following data will be retrieved from the patients filles:

Demographic variables/Patient characteristics

  • Age
  • Gender
  • Smoking status: cigarette and cannabis
  • Patient comorbidity:
  • Diabetes mellitus
  • Hypertension
  • Hand dominance
  • Patient preference: cultural beliefs Variables possibly influencing outcome
  • Ischemia time
  • Workers' compensation
  • Revision surgery
  • Acute post-op complications o Infection
  • Bleeding
  • Vascular thrombosis o Other
  • Chronic complications o Tendon rupture
  • Tendon adhesions
  • Bony malunion
  • Bony non-union
  • Painful neuroma formation o CRPS
  • Other

Evaluation phase and follow-up Each patient's respective hand therapist will then be contacted to be introduced to the research protocol. Instructions regarding patient consent and evaluation tools will be explained. Hand therapists who have the necessary materials and tools to administer the tests and who are willing to participate in the study will receive a copy of the research protocol, detailed instructions regarding their participation and the consent form.

End-of-hand therapy is defined as the last or second-to-last follow-up appointment with the collaborating hand therapist. At this moment, the hand therapist will introduce the patient to the research protocol and will obtain their informed written consent. The DASH score (appendix 1) will then be administered by the occupational therapist in a standardized manner to all participants. Lastly, a quantitative hand function test will be conducted using the Purdue Pegboard according to the standardized procedure described in the user manual by Lafayette Instrument Company, Inc. Both the injured and the non-injured hand will be tested.

A secured online excel sheet will be shared amongst all the collaborating occupational therapists to record the test results.

Statistical Methods:

In order to detect a significant difference in average functional outcome between the two study groups, we will conduct a two-sided t-test using the SPSS software (IBM SPSS, V26, NY). By choosing our cut-off to be 0.05 and a beta of 0.1, we gained 90% power (1 - beta), accordingly we will deem a p-value of ≤ 0.05 as statistically significant. Continuous data will be expressed as mean and standard deviation or median and range, and assessed with t test. Categorical (nominal) data will be summarized as the frequency (%) and we will utilize Pearson Chi-Square and Fisher's exact tests for analysis. We then will analyze the outcomes by logistic regression model comprising two study groups, sex, patient's comorbidities and habit of smoking, and the mechanism of injury. Multiple linear regression analysis will be performed to measure and control confounding variables.

Results obtained from the study will then be used to generate a preoperative decision algorithm for single digit replantation vs. revision amputation. This could help guide clinicians from peripheral centres with questions about medico-legal issues.

Safety Management:

Since the study procedures are not greater than minimal risk, serious adverse events (SAE) are not expected. If any unanticipated problems related to the research involving risks to subjects or others happen during the course of this study (including SAEs) these will be reported to the IRB in accordance with the procedure described in the Mode opératoire normalisé-10: Gestion des évènements indésirables. Adverse events (AEs) that are not serious but that are notable and could involve risks to subjects will be summarized in narrative or other format and submitted to the CÉR at the time of continuing review.

Being tested
Replantation, Primary wound closure
Keywords
Replantation, Single digit, function, DASH

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • ReplantationProcedure or surgery

    Surgical reattachment of a severed body part

  • Primary wound closureProcedure or surgery

    Primary wound closure with removal of exposed bone

Study groups in NCT05155735
Study groupRoleWhat they receive
ReplantationThis group will include subjects who suffered a single digit non-thumb amputation, and whose finger was replanted.
Receives: Procedure: Replantation
Revision AmputationThis group will include subjects who suffered a single digit non-thumb amputation, and whose finger was not replanted.
Receives: Procedure: Primary wound closure

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Functional outcome by DASH score

    Measured by DASH score (higher scores indicate a greater level of disability, score range from 0 to 100)

    Measured: Immediately following patient discharge from hand therapy

  2. Functional outcome by Purdue Pegboard Test

    Measured by Purdue Pegboard Test (higher scores indicate a greater level of dexterity and functionality and are typically compared with normative data stratified on the basis of age, score range depends on how the test is administered)

    Measured: Immediately following patient discharge from hand therapy

  3. Functional outcome by Michigan Hand Questionnaire

    Measured by Michigan Hand Questionnaire (higher scores indicate a greater level of functionality, score range from 0 to 100)

    Measured: Immediately following patient discharge from hand therapy

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted14 Dec 2021
  2. Study start17 Jan 2023
  3. Primary completion15 May 2024 (estimated)
  4. Study completion15 Nov 2024 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
30 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05155735
Sponsor's protocol ID
2022-10233
Status last verified
Jan 2023
First submitted
1 Nov 2021
Last updated
23 Jan 2023
Results posted
No
Data monitoring committee
No
Individual data sharing
No

Publications

  • Stone N, Shah A, Chin B, McKinnon V, McRae M. Comparing digital replantation versus revision amputation patient reported outcomes for traumatic digital amputations of the hand: A systematic review and meta-analysis. Microsurgery. 2021 Jul;41(5):488-497. doi: 10.1002/micr.30738. Epub 2021 Apr 3.

    PubMed 33811398
  • Kaplan FT, Raskin KB. Indications and surgical techniques for digit replantation. Bull Hosp Jt Dis. 2001-2002;60(3-4):179-88.

    PubMed 12102407
  • Tejedor Navarro A, Vendrell Jorda M, Puente Alonso C. Digital replantation/revascularization: predictive factors to microsurgery success-a single-center study. Eur J Trauma Emerg Surg. 2021 Feb;47(1):225-232. doi: 10.1007/s00068-019-01226-x. Epub 2019 Sep 24.

    PubMed 31552437
  • Zhu H, Bao B, Zheng X. A Comparison of Functional Outcomes and Therapeutic Costs: Single-Digit Replantation versus Revision Amputation. Plast Reconstr Surg. 2018 Feb;141(2):244e-249e. doi: 10.1097/PRS.0000000000004024.

    PubMed 29036026
  • Shaterian A, Sayadi LR, Tiourin E, Gardner DJ, Evans GRD, Leis A. Predictors of Hand Function Following Digit Replantation: Quantitative Review and Meta-Analysis. Hand (N Y). 2021 Jan;16(1):11-17. doi: 10.1177/1558944719834658. Epub 2019 Apr 2.

    PubMed 30938181

Questions about this trial

What is this clinical trial studying?

An observational study of Amputation; Traumatic, Hand, run by Centre hospitalier de l'Université de Montréal (CHUM) at 1 site in Canada.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 23 Jan 2023. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Canada. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Ophelie Doucet (5148908000, ophelie.doucet@umontreal.ca), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Functional outcome by DASH score (time frame: Immediately following patient discharge from hand therapy). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT05155735, which also lists 5 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 23 Jan 2023.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in